Home/Filings/4/0001127602-22-001864
4//SEC Filing

Galdes Alphonse 4

Accession 0001127602-22-001864

CIK 0000875045other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:50 PM ET

Size

5.6 KB

Accession

0001127602-22-001864

Insider Transaction Report

Form 4
Period: 2022-01-19
Galdes Alphonse
EVP Pharmaceutical Oper & Tech
Transactions
  • Award

    Common Stock

    2022-01-19+6585,064.131 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    969.366
Footnotes (2)
  • [F1]Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.
  • [F2]Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001789471

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:50 PM ET
Size
5.6 KB